Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Received product really fast
A compounded, prescribed, individually dosed product from a US pharmacy is an entirely different category from an unverified research powder ordered online
Andrew Huberman, a neuroscience professor at Stanford, has stated publicly that "BPC-157 is one of the more interesting peptides because of the gastric juice origin and the acid stability, but the lack of human trials is a real limitation that people tend to overlook." This sentiment reflects the tension between preclinical promise and clinical evidence gaps
[3] [7] As of 2024, retatrutide has no UK marketing authorisation granted by the Medicines and Healthcare products Regulatory Agency (MHRA), and it has not received a marketing authorisation from the European Medicines Agency (EMA)
Claims surrounding BPC-157 benefits derive exclusively from preclinical animal studies, which regulatory bodies do not accept as sufficient evidence for human therapeutic approval
